OCTREOSCAN

This brand name is authorized in Austria, Spain, France, Ireland, Japan, Singapore, United Kingdom

Active ingredients

The drug OCTREOSCAN contains one active pharmaceutical ingredient (API):

1 Indium ¹¹¹In pentetreotide UNII 58TD96H03I - INDIUM CHLORIDE IN-111

Indium(111In)pentetreotide specifically binds to receptors for somatostatin. After radiolabelling pentetreotide with indium( 111In)chloride, the solution obtained is indicated for use as adjunct in the diagnosis and management of receptor bearing gastro-entero-pancreatic neuroendocrine (GEP) tumours and carcinoid tumours, by aiding in their localisation. Read about Indium ¹¹¹In pentetreotide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OCTREOSCAN Kit for radiopharmaceutical preparation	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IB01	Indium (111In) pentetreotide	V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IB Indium (111In) compounds
Discover more medicines within V09IB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60663
Country: FR	Base de données publique des médicaments	Identifier(s): 62889478
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 399410
Country: JP	医薬品医療機器総合機構	Identifier(s): 4300452G1026
Country: SG	Health Sciences Authority	Identifier(s): 11244P